ANTIMICROBIAL LEARNING FOR NAPLEX

Bugs & Drugs.
Understand the match.

Connect the organism, infection site, drug mechanism, and patient factors. Build the reasoning behind antibacterial, antifungal, and antiviral decisions.

Start practice →Explore the drug cards

130 original questions · 25 short sets · 10-question preview without signing in. Membership unlocks all sets.

CHOOSE YOUR FOCUS

Three drug groups. One clinical reasoning habit.

70 ORIGINAL QUESTIONS

Antibacterial

Spectrum, pneumonia, meningitis, resistant infections, urinary infections, and stewardship.

Open antibacterial member sets →

35 ORIGINAL QUESTIONS

Antifungal

Candida, Aspergillus, cryptococcosis, endemic fungi, formulations, and monitoring.

Open antifungal member sets →

25 ORIGINAL QUESTIONS

Antiviral

HIV, hepatitis B and C, herpes viruses, CMV, interactions, and treatment monitoring.

Open antiviral member sets →

Membership includes all 25 sets, explanations, and saved responses. Start with 10 foundation questions in the free preview.

Coverage is the beginning of the decision.

Match the organism and the infection site. Then check susceptibility results, route, dose, patient factors, and current guidance. A laboratory report saying “susceptible” does not make every drug suitable for every infection.

Selected antibacterial spectrum, mechanism, safety, and counseling concepts. This is a learning guide, not a comprehensive antibiotic reference or a patient-specific prescribing tool.

ANTIBACTERIAL FOUNDATIONS

Make the common distinctions clear.

MRSA

Methicillin-resistant Staphylococcus aureus: a resistant form of a Gram-positive bacterium.

Start with an agent with MRSA activity, then check infection site, route, susceptibility, and safety. Ceftaroline has a labeled MRSA skin-infection indication; daptomycin is not indicated for pneumonia.

A useful distinction: Do not assume cefepime covers MRSA because its Gram-negative spectrum is broad.

Sources for this topic

TEFLARO (ceftaroline fosamil) prescribing information
1.1 and 1.2 · Checked 2026-09-13

Daptomycin prescribing information
1.4 · Checked 2026-09-13

Cefepime prescribing information
12.4 · Checked 2026-09-13

Pseudomonas aeruginosa

An aerobic Gram-negative bacterium for which isolate-specific susceptibility is especially useful.

Cefepime, aztreonam, meropenem, and ciprofloxacin may be active when the isolate is susceptible and the site is appropriate. IDSA favors a suitable susceptible traditional non-carbapenem beta-lactam over a carbapenem when both are active.

A useful distinction: Ertapenem is a carbapenem but lacks reliable Pseudomonas activity.

Sources for this topic

IDSA 2026 guidance on antimicrobial-resistant Gram-negative infections
4.1 · Checked 2026-09-13

ATS/IDSA 2016 hospital-acquired and ventilator-associated pneumonia guideline
XVI · Checked 2026-09-13

Enterococcus

Gram-positive bacteria including E. faecalis and E. faecium. VRE means vancomycin-resistant enterococci.

Retain the species name and resistance results. Ampicillin can be useful when susceptible; linezolid has a labeled indication for vancomycin-resistant E. faecium infection, including concurrent bacteremia.

A useful distinction: Cephalosporin generation does not establish enterococcal activity; cefepime is not dependable coverage.

Sources for this topic

Ampicillin injection prescribing information
Indications and Usage · Checked 2026-09-13

ZYVOX (linezolid) prescribing information
1.5 · Checked 2026-09-13

Cefepime prescribing information
12.4 · Checked 2026-09-13

LEARN THE CONNECTIONS

Explore the drugs

Open a card to connect coverage, mechanism, and a practical pearl. Topic filters include both useful activity and important coverage gaps.

Search drug or classLearning topic

11 of 11 drug cards shown.

CeftarolineCephalosporin

Mechanism of action: Binds penicillin-binding proteins (PBPs), disrupting bacterial cell-wall synthesis. Affinity for altered PBP2a helps explain MRSA activity.
Useful activity: Labeled for skin and skin-structure infections due to susceptible MRSA, among other specified organisms.
Do not overlook: Do not transfer a skin-infection indication to every body site. The labeled community-acquired pneumonia indication includes methicillin-susceptible S. aureus (MSSA), not MRSA.
Clinical pearl: An individual cephalosporin may overcome a particular resistance mechanism; this does not extend that activity to the whole class.
Counseling connection: Tell the care team about prior serious beta-lactam reactions and new severe or persistent diarrhea.

Source checks: 2026-09-13

TEFLARO (ceftaroline fosamil) prescribing information
1.1, 1.2, 5.1–5.2 and 12.4

CefepimeCephalosporin

Mechanism of action: Inhibits bacterial cell-wall synthesis through beta-lactam action on PBPs.
Useful activity: Can treat susceptible Pseudomonas aeruginosa and selected other Gram-negative infections.
Do not overlook: Most enterococci and methicillin-resistant staphylococci are resistant. Broad Gram-negative activity does not supply MRSA or reliable Enterococcus coverage.
Clinical pearl: Renal function affects dosing. New confusion, myoclonus, or seizures require urgent assessment for neurotoxicity, even if doses were adjusted.
Counseling connection: Report new confusion or abnormal movements promptly. The team should reassess kidney function and antibiotic therapy.

Source checks: 2026-09-13

Cefepime prescribing information
2.3, 5.2 and 12.4

DaptomycinCyclic lipopeptide

Mechanism of action: Binds bacterial membranes and causes rapid membrane depolarization, disrupting essential cellular processes.
Useful activity: Labeled uses include susceptible S. aureus bloodstream infection, including MRSA, and right-sided infective endocarditis.
Do not overlook: Not indicated for pneumonia or left-sided S. aureus endocarditis. Organism activity alone cannot establish suitability at a body site.
Clinical pearl: Monitor creatine phosphokinase (CPK, also called CK) weekly, and more frequently with statin exposure or rising CPK. In renal impairment, check both renal function and CPK more often than weekly.
Counseling connection: Report new muscle pain or weakness. Tell the team about statins and any new cough, breathing trouble, or fever during treatment.

Source checks: 2026-09-13

Daptomycin prescribing information
1, 5.2, 5.3 and 12.4

LinezolidOxazolidinone

Mechanism of action: Binds 23S ribosomal RNA in the 50S subunit, blocking formation of the functional 70S initiation complex needed for protein synthesis.
Useful activity: Labeled uses include specified MRSA infections and vancomycin-resistant Enterococcus faecium infections, including concurrent bacteremia.
Do not overlook: Not a treatment for Gram-negative infection. Enterococcus species and isolate susceptibility still matter.
Clinical pearl: Monitor a complete blood count (CBC) weekly. Review serotonergic medicines and other interactions before use.
Counseling connection: Provide a complete medication list, including antidepressants. Do not independently stop them; the prescriber should coordinate any changes and symptom monitoring.

Source checks: 2026-09-13

ZYVOX (linezolid) prescribing information
1, 5.1, 5.3 and 12.4

VancomycinGlycopeptide

Mechanism of action: Inhibits bacterial cell-wall synthesis.
Useful activity: Intravenous (IV) therapy has labeled uses for susceptible MRSA systemic infections. Oral capsules act mainly in the intestinal lumen for their specified intestinal indications.
Do not overlook: Oral capsules are not interchangeable with IV therapy for a bloodstream infection. Vancomycin resistance in enterococci rules out assuming useful activity.
Clinical pearl: Route is part of the drug decision. Systemic therapy needs exposure and kidney-function monitoring tailored by the treating team.
Counseling connection: Do not substitute an oral product for an infusion. During an infusion, promptly report flushing, itching, chest discomfort, or breathing symptoms.

Source checks: 2026-09-13

VANCOCIN oral capsules prescribing information
1, 5.2 and 12.3

Vancomycin injection prescribing information
1.1, 5.1–5.2 and 12.4

ZYVOX (linezolid) prescribing information
1.5: vancomycin-resistant E. faecium

AmpicillinAminopenicillin

Mechanism of action: A beta-lactam that inhibits bacterial cell-wall synthesis.
Useful activity: Can treat susceptible enterococcal infections in appropriate clinical settings.
Do not overlook: Do not infer susceptibility from the name Enterococcus. An ampicillin-resistant isolate requires another active approach.
Clinical pearl: Species, susceptibility, infection site, and whether combination therapy is needed must be assessed separately.
Counseling connection: Tell the care team about serious penicillin reactions. Seek urgent help for breathing difficulty or swelling after a dose.

Source checks: 2026-09-13

Ampicillin injection prescribing information
Clinical Pharmacology; Indications and Usage; Warnings

Ampicillin capsules prescribing information (mechanism only)
CLINICAL PHARMACOLOGY—Microbiology—Mechanism of Action

AztreonamMonobactam

Mechanism of action: Inhibits bacterial cell-wall synthesis in susceptible Gram-negative bacteria.
Useful activity: Activity includes susceptible aerobic Gram-negative bacteria such as Pseudomonas aeruginosa.
Do not overlook: Does not supply dependable Gram-positive or anaerobic coverage. A mixed infection may need additional therapy.
Clinical pearl: An antipseudomonal choice can still leave MRSA untreated; account for every clinically significant pathogen.
Counseling connection: Report a history of serious antibiotic allergy and new severe or persistent diarrhea. A monobactam label alone does not replace an allergy assessment.

Source checks: 2026-09-13

AZACTAM (aztreonam) prescribing information
Microbiology; Concurrent Therapy; WARNINGS: allergy assessment; Precautions: Information for Patients

MeropenemCarbapenem

Mechanism of action: Binds PBPs and inhibits bacterial cell-wall synthesis.
Useful activity: Can treat susceptible Pseudomonas aeruginosa and selected other organisms in appropriate infections.
Do not overlook: Does not provide MRSA coverage. Carbapenem resistance can also remove activity against a Gram-negative isolate.
Clinical pearl: Carbapenems can markedly lower valproic acid concentrations and increase breakthrough-seizure risk; coadministration is generally not recommended.
Counseling connection: Tell the care team if you use valproic acid or divalproex, and report seizures or new neurologic symptoms promptly.

Source checks: 2026-09-13

Meropenem for Injection, USP (I.V.) prescribing information — Hikma, updated August 26, 2026
1.1; 5.4: seizure potential; 5.5: interaction with valproic acid; 12.4; 17: patient counseling

ErtapenemCarbapenem

Mechanism of action: Binds PBPs and inhibits bacterial cell-wall synthesis.
Useful activity: Has labeled uses for specified susceptible organisms in selected intra-abdominal, urinary, skin, pelvic, and other infections.
Do not overlook: Lacks reliable Pseudomonas aeruginosa activity. It is not an antipseudomonal substitute for meropenem.
Clinical pearl: Learn the spectrum of each carbapenem individually. Valproic acid interactions also matter with ertapenem.
Counseling connection: Tell the care team about valproic acid or divalproex use and any history of seizures or serious beta-lactam reactions.

Source checks: 2026-09-13

INVANZ (ertapenem) prescribing information
1, 5.1–5.3 and 12.4

ATS/IDSA 2016 hospital-acquired and ventilator-associated pneumonia guideline
XVI: other carbapenems

CiprofloxacinFluoroquinolone

Mechanism of action: Inhibits bacterial DNA gyrase and topoisomerase IV, interfering with DNA processes needed for survival.
Useful activity: Can be active against susceptible Pseudomonas aeruginosa; suitability depends on the infection and the isolate.
Do not overlook: Resistance can emerge. Significant fluoroquinolone safety risks and available alternatives must inform selection.
Clinical pearl: Immediate-release tablets should be taken at least two hours before or six hours after specified multivalent-cation products.
Counseling connection: Review antacids and calcium, iron, or zinc supplements with the pharmacist. Stop the drug and contact the prescriber promptly for tendon pain or new nerve symptoms as directed in the medication guide.

Source checks: 2026-09-13

CIPRO (ciprofloxacin) immediate-release tablets and oral suspension prescribing information — Bayer, updated March 2, 2026
Boxed Warning; 1; 2.4: administration; 5.1–5.3; 7: interactions; 12.4; Medication Guide

NitrofurantoinNitrofuran

Mechanism of action: Bacterial enzymes convert it to reactive intermediates that interfere with multiple bacterial macromolecules and processes.
Useful activity: The monohydrate/macrocrystals product is indicated for uncomplicated cystitis due to susceptible E. coli or S. saprophyticus.
Do not overlook: Not indicated for pyelonephritis or perinephric abscess; no activity against Pseudomonas species.
Clinical pearl: Concentration in urine does not imply useful kidney-tissue exposure. Bladder and kidney infections require different reasoning.
Counseling connection: Take with food. Brownish urine can be expected, but new breathing symptoms, jaundice, or worsening illness need medical assessment.

Source checks: 2026-09-13

Nitrofurantoin monohydrate/macrocrystals prescribing information
Clinical Pharmacology; Microbiology; Indications and Usage; Warnings; Information for Patients

TURN RECOGNITION INTO REASONING

Try it. Explain it. Revisit it.

Each answer choice teaches something. Get a short practice recap, revisit the explanations, and continue when you are ready. All 130 questions and their explanations are available to revisit.

Practice Bugs & Drugs →

Keep building your foundation.

This focused collection supports NAPLEX preparation through mechanisms, medication safety, patient assessment, treatment selection, and monitoring. It complements your broader study plan; practice results are not an exam-readiness assessment.

The companion drug explorer contains 11 antibacterial cards. Antifungal and antiviral learning is included in the practice sets.

Explore Top 300 Drug Learning See currently available products →

Source-check dates appear with each card and question. Drug labels and professional guidance inform this educational content. Report a correction or suggest a topic.